Bogdan Iorga, Ph.D.
Affiliations: | 1998-2002 | École Polytechnique, Palaiseau, Île-de-France, France | |
2002- | ICSN | CNRS, Paris, Île-de-France, France |
Area:
Computational chemistry, Drug design, BioinformaticsGoogle:
"Bogdan Iorga"Mean distance: (not calculated yet)
Parents
Sign in to add mentorPhilippe Savignac | grad student | 1998-2001 | École Polytechnique | |
(Synthèse d'alpha-monohalogénophosphonates par halogénation électrophile) | ||||
Jean-Marc Campagne | post-doc | 2002-2003 | CNRS |
Children
Sign in to add traineeMarie Varin | grad student | 2004-2007 | Université Paris-Sud 11 |
François Martz | grad student | 2011-2014 | Université Paris-Sud 11 |
Maria-Laura-Belén Dabos | grad student | 2015-2018 | Université Paris-Saclay |
Agustín Zavala | grad student | 2015-2018 | Université Paris-Saclay |
Eddy Elisée | grad student | 2016-2019 | Université Paris-Saclay |
Guillaume Bernadat | post-doc | 2009-2010 | CNRS |
Najette Amara | post-doc | 2011-2012 | CNRS |
Georgiana Surpateanu | post-doc | 2009-2013 | CNRS |
Claire Colas | post-doc | 2011-2013 | CNRS |
Cheickna Cissé | post-doc | 2012-2013 | CNRS |
Edithe Selwa | post-doc | 2013-2018 | CNRS |
Nawel Mele | post-doc | 2018-2019 | CNRS |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Dabos L, Raczynska JE, Bogaerts P, et al. (2023) Structural and Biochemical Features of OXA-517: a Carbapenem and Expanded-Spectrum Cephalosporin Hydrolyzing OXA-48 Variant. Antimicrobial Agents and Chemotherapy. e0109522 |
Dahdouh E, Allander L, Falgenhauer L, et al. (2022) Computational Modeling and Design of New Inhibitors of Carbapenemases: A Discussion from the EPIC Alliance Network. International Journal of Molecular Sciences. 23 |
Muntean MM, Muntean AA, Guerin F, et al. (2022) Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers-authors' response. The Journal of Antimicrobial Chemotherapy |
Jousset AB, Oueslati S, Emeraud C, et al. (2021) KPC-39-Mediated Resistance to Ceftazidime-Avibactam in a Klebsiella pneumoniae ST307 Clinical Isolate. Antimicrobial Agents and Chemotherapy. 65: e0116021 |
de Barsy M, Mercuri PS, Oueslati S, et al. (2021) Detection and characterization of VIM-52, a new variant of VIM-1 from clinical isolate. Antimicrobial Agents and Chemotherapy. AAC0266020 |
Muntean MM, Muntean AA, Guerin F, et al. (2021) Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers. The Journal of Antimicrobial Chemotherapy |
Rima M, Emeraud C, Bonnin RA, et al. (2021) Biochemical characterization of OXA-244, an emerging OXA-48 variant with reduced β-lactam hydrolytic activity. The Journal of Antimicrobial Chemotherapy |
Romero E, Oueslati S, Benchekroun M, et al. (2021) Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D). European Journal of Medicinal Chemistry. 219: 113418 |
Çekin ZK, Dabos L, Malkoçoğlu G, et al. (2021) Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital. Diagnostic Microbiology and Infectious Disease. 99: 115174 |
Rivière G, Oueslati S, Gayral M, et al. (2020) NMR Characterization of the Influence of Zinc(II) Ions on the Structural and Dynamic Behavior of the New Delhi Metallo-β-Lactamase-1 and on the Binding with Flavonols as Inhibitors. Acs Omega. 5: 10466-10480 |